Material: Lucite

Musical Note-Themed Lucite Tombstone

Musical note-themed Lucite tombstone celebrating a credit facility for ole, a Canadian music publishing and rights management firm.

(6ALJB63)
1 Image

Lucite Embedment with Pewter Construction Vehicle

Lucite embedment featuring a pewter heavy equipment vehicle marking the acquisition by Breedon Aggregates of Hope Construction Materials.

(6LACA91)
1 Image

Electric Bus-Themed Lucite Tombstone

Lucite tombstone commemorating the roll out of a fleet of all-electric buses for Louisville, Kentucky-based TARC (The Transit Authority of The River City). TARC now operates a total of 15 all-electric buses.

1 Image

Custom Lucite with Embedded Pills

Custom Lucite with embedded pills marking the acquisition by Peruvian pharmacy operator Mifarma of Albis Capital.  (6AGP86)

1 Image

Logo-Themed Lucite Deal Cube

Logo-themed custom Lucite marking the acquisition of Custom Cable, a Florida-based supplier of fiber optic and copper-cable assemblies. (6ARA862)

1 Image

“Double Curve”-Shaped Lucite Tombstone

“Double curve”-shaped Lucite tombstone marking a loan agreement involving Türk Telekom and the European Bank for Reconstruction and Development (EBRD) The funds will be used for the expansion of Turkey’s mobile broadband network. (6LACC21)

1 Image

Custom Lucite Prism Tombstone

Prism-shaped Lucite marking the acquisition by Swiss firm Huber + Suhner of Polatis. Polatis is jointly headquartered in the U.S. and U.K. and is a developer of all-optical switches.

(6ALMD61)
1 Image

iPhone-Themed Lucite Tombstone

iPhone-themed Lucite tombstone marking the acquisition of a stake in Irish telecom group Eir. The purchaser, GIC, is the sovereign wealth fund of Singapore.

(6AKLB83)
1 Image

Pill-Themed Financial Tombstone (Back View)

Back view of pill-themed financial tombstone marking the purchase of New Zealand Pharmaceuticals (NZD). The acquirer was Australian private equity firm Archer Capital.

(6ALR257)
2 Images
Pill-shaped Lucite tombstone commemorating the acquisition of New Zealand Pharmaceuticals by Sydney-based Archer Capital. NZD is a specialty chemicals manufacturer headquartered in Palmerston North.